Cargando…
Angiotensinogen and Risk of Stroke Events in Patients with Type 2 Diabetes Mellitus
BACKGROUND: Activation of the renin-angiotensin system (RAS) in diabetic patients is a vital pathophysiological mechanism of cardiovascular complications. AIM: We aimed to assess whether serum and urinary angiotensinogen levels could predict the risk of stroke events in patients with type 2 diabetes...
Autores principales: | Liu, Tao, Liu, Weihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846557/ https://www.ncbi.nlm.nih.gov/pubmed/35177918 http://dx.doi.org/10.2147/DMSO.S335746 |
Ejemplares similares
-
Changes in Urinary Angiotensinogen Associated with Deterioration of Kidney Function in Patients with Type 2 Diabetes Mellitus
por: Lee, Min Jin, et al.
Publicado: (2017) -
Urinary angiotensinogen antedates the development of stage 3 CKD in patients with type 1 diabetes mellitus
por: Ba Aqeel, Sheeba, et al.
Publicado: (2019) -
Renin-Angiotensin System Gene Variants and Type 2 Diabetes Mellitus: Influence of Angiotensinogen
por: Joyce-Tan, Siew Mei, et al.
Publicado: (2016) -
Urinary angiotensinogen is a marker for tubular injuries in patients with type 2 diabetes
por: Terami, Takahiro, et al.
Publicado: (2013) -
Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus
por: Sawaguchi, Makoto, et al.
Publicado: (2012)